Feed SFZN.SW
SF
Siegfried Holding AG
SFZN.SW · SIX
CHF 79.50 +2.05% (+CHF 1.60)
1M +9.86%
Market Cap CHF 3.4B
P/E Ratio 20.27x
Div. Yield 0.51%
ROE 16.87%
Bulios Fair Price
CHF 58.65
26.2% downside
Preț actual
CHF 79.5
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile SFZN.SW sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
41 /100
Fair P/E 20.27x
EV/EBITDA 12.69x
P/S 2.58x
Growth
22 /100
Declining EPS growth 52.66%
Rev. growth 2.60%
FCF growth 19.75%
Profitability
48 /100
Moderate Gross margin 26.54%
Net margin 12.70%
Op. margin 15.84%
Quality
63 /100
Average ROIC 9.28%
ROE 16.87%
ROA 7.83%
Debt
86 /100
Low Debt/Equity 0.51x
Current ratio 2.00x
Int. coverage 29.47x
Stability
83 /100
Stable Beta 0.81x
Rev. volatility 0.80%
EPS volatility 45.76%
Întreabă StockBot despre SFZN.SW
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marcel Imwinkelried
Employees
3,891
Headquarters
Zofingen
Evenimente viitoare
21 AUG.
Earnings
Upcoming earnings report